EUVIMEDEUVIMED entdecken
Crossref

New 8-hydroxyquinoline derivatives as promising therapeutic approaches targeting neurodegeneration

Marques-Oliveira, R., Ana Rita Alfenim, Pedro Soares, Francisco de Oliveira Borges, Remião, F., Fernandes, C., Silva, R.

Science Letters · 17.04.2023

DOI: 10.48797/sl.2023.92 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Letters, erschienen am 17.04.2023. Verfasst von Marques-Oliveira und 10 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alzheimer's disease, Parkinson's disease, and Amyotrophic lateral sclerosis are recognized as the most prevalent neurodegenerative diseases (NDs), presenting a huge burden for society. These diseases share common pathophysiological mechanisms, such oxidative stress, dysfunction in iron metabolism, ferroptosis, and protein misfolding [1-4]. Given their powerful metal chelating and antioxidant properties, 8-hydroxyquinoline (8-HQs) derivatives have emerged as attractive therapeutic approaches for the development of innovative therapies for NDs [5].

Objective

To assess, in vitro, the neuroprotective effects of 12 newly synthesized 8-HQs with iron chelation and radical scavenging capacity, using differentiated neuronal SH-SY5Y cells as an in vitro model.

Methods

The cytotoxicity of 8-HQs was initially evaluated using the MTT reduction and neutral red uptake assays, 24 hours after exposure, to select non-cytotoxic concentrations. The neuroprotective effects of the 8-HQs against the cytotoxicity induced by iron (III), erastin (a ferroptosis inducer), or by the combination of the two aggressors, were then evaluated. Their capacity to decrease tert-butyl hydroperoxide (t-BHP)-induced cytotoxicity was also investigated, aiming to elucidate the potential of the novel 8-HQs derivatives to counteract oxidative stress. The most promising 8-HQs were also tested for their ability to protect against the neurotoxin 1-methyl-4-phenylpyridinium (MPP+), which is frequently used to mimic Parkinson's disease in in vitro models [6].

Results

Some of the 8-HQs significantly protected SH-SY5Y cells against the cytotoxicity induced by iron (III), erastin, or by the combined effects iron (III) + erastin. Moreover, several 8-HQs also remarkably reduced the cytotoxic effects induced by both t-BHP and MPP+.

Conclusions

The 8-HQs showed outstanding neuroprotective properties against the harmful effects induced by distinct chemical aggressors, highlighting their potential to become effective disease-modifying agents for counteracting neurodegeneration.

Schlagwörter

8-hydroxyquinoline derivativesneurodegenerative diseasesneuroprotectionferroptosisiron chelationoxidative stressfree radical scavengingSH-SY5Y cellserastintert-butyl hydroperoxide

Zitieren

APA

Marques-Oliveira, R., Alfenim, A. R., Soares, P., Borges, F. D. O., Remião, F., Fernandes, C., Silva, & R. (2023). New 8-hydroxyquinoline derivatives as promising therapeutic approaches targeting neurodegeneration. Science Letters. https://doi.org/10.48797/sl.2023.92

Vancouver

Marques-Oliveira, R., Alfenim AR, Soares P, Borges FDO, Remião, et al. New 8-hydroxyquinoline derivatives as promising therapeutic approaches targeting neurodegeneration. Science Letters. 2023. doi:10.48797/sl.2023.92

BibTeX
@article{MarquesOliveira2023,
  author = {Marques-Oliveira and R. and Alfenim, Ana Rita and Soares, Pedro and Borges, Francisco de Oliveira and Remião and F. and Fernandes and C. and Silva and R.},
  title = {New 8-hydroxyquinoline derivatives as promising therapeutic approaches targeting neurodegeneration},
  journal = {Science Letters},
  year = {2023},
  doi = {10.48797/sl.2023.92}
}
Kostenlos starten →